Loading...
OTCM
PMSNF
Market cap5mUSD
Jan 17, Last price  
0.03USD
Name

Proteome Sciences PLC

Chart & performance

D1W1MN
OTCM:PMSNF chart
P/E
—
P/S
1.85
EPS
—
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
-4.43%
Div Yld LY
—
Div Yld TTM
—
Revenues
4m
-23.14%
68,469265,593849,4871,305,69401,021,1661,152,9672,136,6811,560,7151,882,0002,744,0003,380,0003,049,0004,634,0004,712,0005,124,0007,780,0005,028,0004,887,0003,756,000
Net income
-3m
L-10.13%
-5,637,690-5,252,029-4,624,468-4,009,8304,563,163-3,957,341-4,253,594-3,149,159-3,566,481-2,718,000-2,280,000-2,497,000-1,313,000149,000295,00072,0001,325,000-2,443,000-3,406,000-3,061,000
CFO
-46k
L-94.43%
-3,606,000-4,093,000-4,122,000-2,972,0004,003,000-5,166,000-3,353,367-11,550,000,000-6,267,000,00046,633,000,000-31,695,000,00055,473,000,000-14,780,000,000-21,451,000,0001,583,000793,0002,140,000-481,000-826,000-46,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Proteome Sciences Plc is a provider of contract proteomics services to enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. It offers proprietary technologies for protein and peptide biomarker discovery, validation, and assay development. The company focuses on developing proprietary protein biomarkers for neurological diseases, oncology, and organ transplant rejection. Proteome Sciences was founded on December 10, 1993 and is headquartered in Cobham, the United Kingdom.

Key people

Christopher Pearce
Executive Chairman of the Board · since 2025
Stefan Fuhrmann
Finance Director · since 2017
Richard Dennis
Chief Commercial Officer, Executive Director · since 2018
Ian Pike
Chief Scientific Officer, Executive Director · since 2020
Martin Diggle
Non-Executive Director · since 2014
Roger McDowell
Non-Executive Independent Director · since 2019
Ursula Ney
Non-Executive Independent Director · since 2018
URL
https://www.proteomics.com/
IPO date
Oct 03, 1995
Employees
27
Domiciled in
GB
Incorporated in
GB
Headquarters & legal address
COVEHAM HOUSE
DOWNSIDE BRIDGE ROAD
COBHAM, SRY KT11 3EP
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT